Loading
A phase 3 trial of Shark cartilage in Breast cancer and Colorectal cancer, run by Alliance for Clinical Trials in Oncology, completed.
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer is a phase 3 interventional study registered as NCT00026117 by Alliance for Clinical Trials in Oncology, with 88 participants recorded, started 2001-08 and reaching its primary completion in 2006-09. Interventions recorded: BenFin, placebo. Conditions recorded: Breast Cancer, Colorectal Cancer.
Linked to the technology Shark cartilage because the registry's title names it ("shark cartilage") and Breast cancer and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Alliance for Clinical Trials in Oncology, Breast cancer (all types) and the tag pipeline.
Shares Alliance for Clinical Trials in Oncology, Breast cancer (all types) and the tag pipeline.
Shares Shark cartilage (AE-941, Neovastat) and the tag pipeline.
Shares Shark cartilage (AE-941, Neovastat) and the tag pipeline.
Shares Alliance for Clinical Trials in Oncology and the tag pipeline.
Shares Breast cancer (all types), Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/